[SL-01-1]From MS to NMOSD and MOGAD: its path, Japan's contribution and challenges
○Kazuo Fujihara1,2(1.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan, 2.Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Japan)

Password required to view
Abstract password authentication.
You can find the password on page 18 of the program book.
You can find the password on page 18 of the program book.
